4th Quarter - Report — INVARIANT LLC for ANTHEIA (2022)

Firm

INVARIANT LLC

Client

ANTHEIA

Income

$60,000

Expenses

—

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Highlight Antheia's use of synthetic biology to produce active pharmaceutical ingredients.

Lobbyist	Covered position, as disclosed
CHRISTOPHER GILLOTT	—
BENJAMIN KLEIN	—
ANNABELL MCWHERTER STOKES	—
KATHRYN WISE	—

Contacted: Health & Human Services, Dept of (HHS); SENATE; Food & Drug Administration (FDA); Office of Management & Budget (OMB); Natl Economic Council (NEC); HOUSE OF REPRESENTATIVES; Office of Science & Technology Policy (OSTP)

Defense DEF

Highlight Antheias use of synthetic biology to produce active pharmaceutical ingredients.

Lobbyist	Covered position, as disclosed
CHRISTOPHER GILLOTT	—
BENJAMIN KLEIN	—
STEPHEN WEYLER	—
KATHRYN WISE	—

Contacted: SENATE; HOUSE OF REPRESENTATIVES; Defense, Dept of (DOD)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.